Figure 2From: Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study Dose assignment scheme to LD and HD 5-FU in part I.Back to article page